Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02466802Phase 1Completed
Study of Regorafenib and Sildenafil for Advanced Solid Tumors
Solid Tumor
PrincipalinvestigatorStart date: 2015-07-01
NCT01375699Phase 1Completed
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
Breast CancerGastrointestinal CancerGenitourinary Cancer+2 more
PrincipalinvestigatorStart date: 2011-08-11
NCT01075113Phase 1Completed
Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer
Liver Cancer
PrincipalinvestigatorStart date: 2010-08-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02466802Phase 1PrincipalInvestigator

Study of Regorafenib and Sildenafil for Advanced Solid Tumors

Solid Tumor
Completed
NCT01375699Phase 1PrincipalInvestigator

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Breast CancerGastrointestinal CancerGenitourinary Cancer+2 more
Completed
NCT01075113Phase 1PrincipalInvestigator

Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer

Liver Cancer
Completed
NCT01427322Early Phase 1PrincipalInvestigator

Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease

Epithelial Cancer
Terminated

All 4 trials loaded